GlaxoSmithKline Bexsero achieves primary and secondary endpoints with reduced 3-dose schedule in safety and immunogenicity study in infants and children
GSK presented new data for its meningococcal group B vaccine, Bexsero®,1 comparing safety ...
GSK presented new data for its meningococcal group B vaccine, Bexsero®,1 comparing safety ...
Swedish Orphan Biovitrum AB and Biogen announced that the European Commission (EC) has approved Alprolix® (rFIXFc), their extended half-life therapy, ...
Swedish Orphan Biovitrum AB and Biogen announced that the European Commission (EC) has approved Alprolix® (rFIXFc), their extended half-life therapy, ...
Merck, a leading science and technology company, will exhibit a new range of products and solutions at Analytica 2016, the ...
• Detects biomarkers of horse infection, inflammation, immune response and general health • Addresses unmet needs of equine research ...
fizer Inc announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) approved ...
AstraZeneca announced that it has completed the divestment of the global rights to Imdur, outside the US, to China Medical ...
Novartis announced that the US Food and Drug Administration (FDA) has granted three Breakthrough Therapy Designations for Ilaris® (canakinumab) to ...
AstraZeneca announced that it has entered into a licensing agreement with Ironwood Pharmaceuticals for the exclusive US rights to Zurampic® ...
Bristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Opdivo ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.